Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Vidya C. Sinha"'
Autor:
Abena B. Redwood, Xiaomei Zhang, Sahil B. Seth, Zhongqi Ge, Wendy E. Bindeman, Xinhui Zhou, Vidya C. Sinha, Timothy P. Heffernan, Helen Piwnica-Worms
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-9 (2021)
Abstract The relationship between ATR/Chk1 activity and replication stress, coupled with the development of potent and tolerable inhibitors of this pathway, has led to the clinical exploration of ATR and Chk1 inhibitors (ATRi/Chk1i) as anticancer the
Externí odkaz:
https://doaj.org/article/f52fc4ae77174e23822274182d58cffc
Autor:
Vidya C. Sinha, Amanda L. Rinkenbaugh, Mingchu Xu, Xinhui Zhou, Xiaomei Zhang, Sabrina Jeter-Jones, Jiansu Shao, Yuan Qi, John A. Zebala, Dean Y. Maeda, Florencia McAllister, Helen Piwnica-Worms
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-17 (2021)
The classification of breast lesions as indolent or aggressive to tailor treatment is crucial. Here, the authors use single-cell transcriptomics and multiparametric imaging of a breast cancer mouse model, report distinct tumor-immune features for the
Externí odkaz:
https://doaj.org/article/edf450673bba4946ad0410cdc2344397
In contrast to premalignant lesions, ErbB2-initiated tumors in wildtype and ARF-null mammary glands exhibit comparable senescence and DDR.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77432d2d4cbd0a2a09de95909a6cb4f1
https://doi.org/10.1158/1541-7786.22515048
https://doi.org/10.1158/1541-7786.22515048
Loss of ARF does not impact proliferation, autophagy, or DNA damage complex formation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::516871da59542b1d43be915b1f47f731
https://doi.org/10.1158/1541-7786.22515054
https://doi.org/10.1158/1541-7786.22515054
Loss of ARF results in diminished p53-function and impaired senescence, but does not impact apoptosis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c7e852090b1e11aea7106307024946e
https://doi.org/10.1158/1541-7786.22515063.v1
https://doi.org/10.1158/1541-7786.22515063.v1
p16 plays a minor role in mediating senescence in the mammary gland.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89889669302894d16ffc61ee9dcb8fa7
https://doi.org/10.1158/1541-7786.22515060.v1
https://doi.org/10.1158/1541-7786.22515060.v1
ARF-loss does not affect mammary gland development or rate of infection.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60b93054e3677e9b7d1106696ed373a4
https://doi.org/10.1158/1541-7786.22515057
https://doi.org/10.1158/1541-7786.22515057
Loss of p53 does not diminish DDR following ErbB2 activation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8835a7cedd9363e21f43d2d946bb7200
https://doi.org/10.1158/1541-7786.22515051
https://doi.org/10.1158/1541-7786.22515051
Publikováno v:
Cancer Research. 79:P3-07
This abstract was withdrawn by the authors. Citation Format: Rinkenbaugh AL, Sinha VC, Zhang X, Shao J, Piwnica-Worms H. Withdrawn [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphi
Autor:
Amanda L. Rinkenbaugh, Vidya C. Sinha, Pankaj Singh, Yuan Qi, Jiansu Shao, Xiaomei Zhang, Gloria V. Echeverria, W. Fraser Symmans, Stacy L. Moulder, Helen Piwnica-Worms
Publikováno v:
Cancer Research. 82:1595-1595
Shifts in tumor cell phenotype in response to selective pressures (i.e. changing microenvironments, drug treatments) pose one of the biggest obstacles to successful breast cancer therapies. Phenotypically diverse breast tumor and stroma subpopulation